Cargando…
Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature
KRAS mutations occur frequently in colorectal cancers (CRC) and predict lack of response to anti-epidermal growth factor receptor (EGFR) monoclonal antibody therapy. CRC BRAF mutations, most commonly at V600E, occur less than 10% of the time, and occur usually in KRAS wild-type tumors, and more freq...
Autores principales: | Sahin, Ibrahim Halil, Kazmi, Syed M.A., Yorio, Jeffrey T., Bhadkamkar, Nishin A., Kee, Bryan K., Garrett, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619093/ https://www.ncbi.nlm.nih.gov/pubmed/23569465 http://dx.doi.org/10.7150/jca.3619 |
Ejemplares similares
-
A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas
por: Yorio, Jeffrey T., et al.
Publicado: (2012) -
Are All Mutations the Same? A Rare Case Report of Coexisting Mutually Exclusive KRAS and BRAF Mutations in a Patient with Metastatic Colon Adenocarcinoma
por: Vittal, Anusha, et al.
Publicado: (2017) -
BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
por: Chiappetta, Caterina, et al.
Publicado: (2015) -
Comprehensive analysis of mutually exclusive alternative splicing in C. elegans
por: Kuroyanagi, Hidehito, et al.
Publicado: (2014) -
Takotsubo cardiomyopathy and acute coronary syndromes: Are they always mutually exclusive?
por: Yalta, Kenan, et al.
Publicado: (2018)